Abstract
Glucocorticoids play an essential role in embryonic development and tissue homeostasis and possess important antiinflammatory and immunosuppressive properties. Due to their very wide spectrum of activity, glucocorticoids are one of the most commonly used drugs-used in the treatment of asthma, arthritis, autoimmune diseases and shock/SIRS. Glucocorticoids are a main component of treatment regimens in hematological malignancies due to their pro-apoptotic properties and are also used as co-treatment several other cancers and chemotherapy regimens including those in breast cancer treatment. In breast cancer, however, glucocorticoids may have diverse effects and could inhibit chemosensitivity. Additionally, glucocorticoids through their receptor may interact with ER in a feedback loop regulating each others activities. The normal variation of glucocorticoid levels with time of the day, menstrual cycle or year could have a interesting chronobiological interaction with the well recorded variation in breast cancer proliferation and metastatic potential. Glucocorticoids could play a very complex role in breast cancer epidemiology, biology and treatment; this review aims to present a comprehensive discussion as well as speculate future directions for research.
Keywords: Glucocorticoids, steroids, breast cancer, review, circadian, paracrine, glucocorticoid receptor, treatment, homeostasis, asthma, arthritis, autoimmune diseases, chemotherapy, leukemia, lymphoma, CNS, Oestrogen, progesterone, nuclear factor-B, Dexomethasone, sulfotransferase, rheumatoid arthritis, metabolic syndrome, NSAID, MCF10A-Myc mammary carcinoma cells, RU486, SGK-1, Serum and glucocorticoid induced Kinase 1, MAP kinase phosphatase-1, Trastuzumab-induced cell growth, CIRCADIAN RHYTHMS, Estrogen receptors, Human Epidermal Growth Factor Receptor-2, Endocrine Therapy
Current Pharmaceutical Design
Title: Role of Glucocorticoids in Breast Cancer
Volume: 16 Issue: 32
Author(s): Jayant S. Vaidya, Gustavo Baldassarre, Mangesh A. Thorat and Samuele Massarut
Affiliation:
Keywords: Glucocorticoids, steroids, breast cancer, review, circadian, paracrine, glucocorticoid receptor, treatment, homeostasis, asthma, arthritis, autoimmune diseases, chemotherapy, leukemia, lymphoma, CNS, Oestrogen, progesterone, nuclear factor-B, Dexomethasone, sulfotransferase, rheumatoid arthritis, metabolic syndrome, NSAID, MCF10A-Myc mammary carcinoma cells, RU486, SGK-1, Serum and glucocorticoid induced Kinase 1, MAP kinase phosphatase-1, Trastuzumab-induced cell growth, CIRCADIAN RHYTHMS, Estrogen receptors, Human Epidermal Growth Factor Receptor-2, Endocrine Therapy
Abstract: Glucocorticoids play an essential role in embryonic development and tissue homeostasis and possess important antiinflammatory and immunosuppressive properties. Due to their very wide spectrum of activity, glucocorticoids are one of the most commonly used drugs-used in the treatment of asthma, arthritis, autoimmune diseases and shock/SIRS. Glucocorticoids are a main component of treatment regimens in hematological malignancies due to their pro-apoptotic properties and are also used as co-treatment several other cancers and chemotherapy regimens including those in breast cancer treatment. In breast cancer, however, glucocorticoids may have diverse effects and could inhibit chemosensitivity. Additionally, glucocorticoids through their receptor may interact with ER in a feedback loop regulating each others activities. The normal variation of glucocorticoid levels with time of the day, menstrual cycle or year could have a interesting chronobiological interaction with the well recorded variation in breast cancer proliferation and metastatic potential. Glucocorticoids could play a very complex role in breast cancer epidemiology, biology and treatment; this review aims to present a comprehensive discussion as well as speculate future directions for research.
Export Options
About this article
Cite this article as:
S. Vaidya Jayant, Baldassarre Gustavo, A. Thorat Mangesh and Massarut Samuele, Role of Glucocorticoids in Breast Cancer, Current Pharmaceutical Design 2010; 16 (32) . https://dx.doi.org/10.2174/138161210793797906
DOI https://dx.doi.org/10.2174/138161210793797906 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Micro-flow Immunosensor Based on Thin-film Interdigitated Gold Array Microelectrodes for Cancer Biomarker Detection
Current Drug Delivery Cytokines in HIV-Infection - Inflammatory Damage or Therapeutic Potential?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Up-Regulation of MBD1 Promotes Pancreatic Cancer Cell Epithelial-Mesenchymal Transition and Invasion by Epigenetic Down-Regulation of E-Cadherin
Current Molecular Medicine AMI and Anabolic-Androgenic Steroids: Case Report with Systematic Review
Current Cardiology Reviews Enhanced Anticancer Activity and Apoptosis Effect of Bioactive Compound Quercetin Extracted from <i>Ocimum sanctum</i> Leaves
Current Nanomedicine Transcription Factors in Autoimmune Diseases
Current Pharmaceutical Design Recent Progress in Selenophenes Synthesis from Inorganic Se-Precursors
Current Organic Synthesis Nuclear Receptor SHP as a Potential Therapeutic Target for Liver Cancer
Current Cancer Therapy Reviews Nitric Oxide-Derived Oxidants with a Focus on Peroxynitrite: Molecular Targets,Cellular Responses and Therapeutic Implications
Current Pharmaceutical Design Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Letters in Drug Design & Discovery PROTACs: A Hope for Breast Cancer Patients?
Anti-Cancer Agents in Medicinal Chemistry Aptamers: Potential Applications to Pancreatic Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry FDG-PET/CT Imaging of Infected Bones and Prosthetic Joints
Current Molecular Imaging (Discontinued) New Approaches to Photodynamic Therapy from Types I, II and III to Type IV Using One or More Photons
Anti-Cancer Agents in Medicinal Chemistry Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity
Current Neuropharmacology The Evaluation of Potential Cytotoxic Effect of Different Proton Pump Inhibitors on Different Human Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy in Lung Transplantation
Current Gene Therapy Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein
Anti-Cancer Agents in Medicinal Chemistry Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours
Current Signal Transduction Therapy